Bank of Montreal Can lessened its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 7.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 834,566 shares of the financial services provider's stock after selling 66,774 shares during the quarter. Bank of Montreal Can owned 0.12% of MetLife worth $68,334,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. Geode Capital Management LLC increased its holdings in shares of MetLife by 1.3% during the 4th quarter. Geode Capital Management LLC now owns 11,931,536 shares of the financial services provider's stock worth $973,901,000 after acquiring an additional 158,107 shares during the last quarter. Norges Bank acquired a new position in MetLife in the 4th quarter valued at $730,716,000. Bank of New York Mellon Corp increased its holdings in MetLife by 109.2% in the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider's stock valued at $722,727,000 after buying an additional 4,606,748 shares during the period. Clearbridge Investments LLC increased its stake in MetLife by 43.7% in the fourth quarter. Clearbridge Investments LLC now owns 5,663,177 shares of the financial services provider's stock valued at $463,701,000 after acquiring an additional 1,723,461 shares during the last quarter. Finally, Nordea Investment Management AB raised its holdings in shares of MetLife by 16.8% during the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider's stock worth $347,735,000 after buying an additional 608,224 shares in the last quarter. Institutional investors own 94.99% of the company's stock.
Analysts Set New Price Targets
A number of research analysts have recently commented on MET shares. Morgan Stanley dropped their target price on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Wells Fargo & Company cut their target price on shares of MetLife from $97.00 to $91.00 and set an "overweight" rating on the stock in a research report on Thursday, April 10th. UBS Group upped their price target on shares of MetLife from $94.00 to $98.00 and gave the stock a "buy" rating in a report on Wednesday, April 2nd. Cowen reissued a "buy" rating on shares of MetLife in a report on Friday, March 7th. Finally, BMO Capital Markets assumed coverage on MetLife in a report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 target price for the company. Two research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $92.46.
Read Our Latest Stock Report on MetLife
MetLife Trading Up 0.5 %
MET stock traded up $0.39 during trading on Tuesday, hitting $73.34. The company had a trading volume of 545,517 shares, compared to its average volume of 3,835,297. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a one year low of $65.21 and a one year high of $89.05. The business has a 50-day moving average of $80.08 and a 200-day moving average of $82.40. The stock has a market cap of $49.96 billion, a PE ratio of 12.28, a PEG ratio of 0.65 and a beta of 0.89.
MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts' consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Research analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles

Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.